William N. Rom

Active 1978–2020

103
Papers
18,930
Citations
87
h-index
103
i10-index

Citations

Citations per year for William N. Rom1933: 1 citations1972: 1 citations1981: 2 citations1982: 2 citations1984: 1 citations1985: 2 citations1986: 1 citations1987: 1 citations1988: 7 citations1989: 13 citations1990: 29 citations1991: 23 citations1992: 13 citations1993: 15 citations1994: 22 citations1995: 45 citations1996: 85 citations1997: 109 citations1998: 147 citations1999: 133 citations2000: 131 citations2001: 105 citations2002: 138 citations2003: 146 citations2004: 128 citations2005: 108 citations2006: 102 citations2007: 109 citations2008: 99 citations2009: 132 citations2010: 141 citations2011: 113 citations2012: 124 citations2013: 118 citations2014: 147 citations2015: 136 citations2016: 122 citations2017: 151 citations2018: 135 citations2019: 421 citations2020: 485 citations2021: 476 citations2022: 400 citations2023: 283 citations2024: 415 citations2025: 182 citations2026: 10 citations1934–1971: no citations, so these years are not shown1973–1980: no citations, so these years are not shown1983: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,164 citing papers, 30.5% of this breakdownChina: 736 citing papers, 10.4% of this breakdownUnited Kingdom: 492 citing papers, 6.9% of this breakdownGermany: 296 citing papers, 4.2% of this breakdownItaly: 272 citing papers, 3.8% of this breakdownFrance: 220 citing papers, 3.1% of this breakdownCanada: 206 citing papers, 2.9% of this breakdownIndia: 192 citing papers, 2.7% of this breakdownJapan: 178 citing papers, 2.5% of this breakdownAustralia: 173 citing papers, 2.4% of this breakdownNetherlands: 155 citing papers, 2.2% of this breakdownSpain: 143 citing papers, 2% of this breakdown
0%30.5%Other 26.4%

Fields

  • Medicine48.1%
  • Biochemistry, Genetics and Molecular Biology30.5%
  • Immunology and Microbiology7%
  • Engineering5%
  • Health Professions2.2%
  • Environmental Science1.9%
  • Other5.3%

Topics

  • Tuberculosis Research and Epidemiology4.5%
  • Gut microbiota and health4.1%
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis2.9%
  • Mycobacterium research and diagnosis2.3%
  • Advanced Chemical Sensor Technologies1.7%
  • Chronic Obstructive Pulmonary Disease (COPD) Research1.7%
  • Other82.8%

Coauthors

All papers

Open in search
  1. Enrichment of the lung microbiome with oral taxa is associated with lung inflammation of a Th17 phenotype

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Microbiology 2016 cited by 692

  2. Airway Microbiota Is Associated with Upregulation of the PI3K Pathway in Lung Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2018 cited by 457

  3. Lower Airway Dysbiosis Affects Lung Cancer Progression

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , William Moore, Aristotelis Tsirigos, Adriana Heguy, William N. Rom, Daniel H. Sterman, Harvey I. Pass, Jose C. Clemente, Huilin Li, Richard Bonneau, Kwok-Kin Wong, Thales Papagiannakopoulos, Leopoldo N. Segal - Cancer Discovery 2020 cited by 305

  4. Enrichment of lung microbiome with supraglottic taxa is associated with increased pulmonary inflammation

    Authors: , , , , , , , , , , - Microbiome 2013 cited by 474

  5. Standard Operating Procedures for Serum and Plasma Collection: Early Detection Research Network Consensus Statement Standard Operating Procedure Integration Working Group

    Authors: , , , , , , , , , , , - Journal of Proteome Research 2008 cited by 736

  6. microRNAs Derived from Circulating Exosomes as Noninvasive Biomarkers for Screening and Diagnosing Lung Cancer

    Authors: , , , , , , - Journal of Thoracic Oncology 2013 cited by 452

  7. Anaerobic Bacterial Fermentation Products Increase Tuberculosis Risk in Antiretroviral-Drug-Treated HIV Patients

    Authors: , , , , , , , , , , , , , , , - Cell Host & Microbe 2017 cited by 152

  8. A Panel of Novel Detection and Prognostic Methylated DNA Markers in Primary Non–Small Cell Lung Cancer and Serum DNA

    Authors: , , , , , , , , , , , - Clinical Cancer Research 2017 cited by 178

  9. Randomised, double-blind, placebo-controlled trial with azithromycin selects for anti-inflammatory microbial metabolites in the emphysematous lung

    Authors: , , , , , , , , , - Thorax 2016 cited by 176

  10. Obliterative Bronchiolitis

    Authors: , , , - New England Journal of Medicine 2014 cited by 315

  11. Assessment of Plasma Proteomics Biomarker’s Ability to Distinguish Benign From Malignant Lung Nodules

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David K. Madtes, Jesse J. Hubbard, Wm. J. McConnell, Kathy Robinson, Alexandra Lackey, Loretta Jacques, E. Kuo, Veta Markland-Gentles, Pierre P. Massion, A. Muterspaug, Joseph Leach, Katharina Rothe, William N. Rom, Harvey I. Pass, Amber Sorenson, Asha N. Chesnutt, A. Georgeson, Alex Balekian, Joshua Fisher, Rajmohan Murali, Alyssa K. Overton, Neeraj Desai, Anna Levesque, William Krimsky, S. King, Anil Vachani, K. Maletteri, Kathryn F. Mileham, L. Carter, Guini Hong, Jie Ma, Kirk Voelker, Heather Barrentine, Ronnie Aronson, Meredith C. Henderson, James Lamberti, C. Krawiecki, Amy Hajari Case, Lawson Wilkins, J.M. Ayers, K. Fangmann, John N. Landis, L. DeSouza, Zane T. Hammoud, D. Kah, Julian Sanchez, L. Murdoch - CHEST Journal 2018 cited by 163

  12. Epigenetically regulated PAX6 drives cancer cells toward a stem-like state via GLI-SOX2 signaling axis in lung adenocarcinoma

    Authors: , , , , , , , , - Oncogene 2018 cited by 83

  13. Aldehydes are the predominant forces inducing DNA damage and inhibiting DNA repair in tobacco smoke carcinogenesis

    Authors: , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2018 cited by 122

  14. Detection of Lung Cancer With Volatile Markers in the Breatha

    Authors: , , , , , , , - CHEST Journal 2003 cited by 572

  15. Basic pathogenetic mechanisms in silicosis: current understanding

    Authors: , , - Current Opinion in Pulmonary Medicine 2005 cited by 326

  16. Detection of lung cancer using weighted digital analysis of breath biomarkers

    Authors: , , , , , , , , , , , , - Clinica Chimica Acta 2008 cited by 230

  17. Lung Microbiome for Clinicians. New Discoveries about Bugs in Healthy and Diseased Lungs

    Authors: , , - Annals of the American Thoracic Society 2014 cited by 158

  18. Prediction of lung cancer using volatile biomarkers in breath1

    Authors: , , , , , , , , , , , , - Cancer Biomarkers 2007 cited by 323

  19. Distal Airway Function in Symptomatic Subjects With Normal Spirometry Following World Trade Center Dust Exposure

    Authors: , , , , , , , , - CHEST Journal 2007 cited by 192

  20. Differential Role for CD80 and CD86 in the Regulation of the Innate Immune Response in Murine Polymicrobial Sepsis

    Authors: , , , , , , , , , - PLoS ONE 2009 cited by 128

  21. Immunomodulation with Recombinant Interferon-γ1b in Pulmonary Tuberculosis

    Authors: , , , , , , , , , , - PLoS ONE 2009 cited by 119

  22. Metabolomic Markers of Altered Nucleotide Metabolism in Early Stage Adenocarcinoma

    Authors: , , , , , , , , , , , , - Cancer Prevention Research 2015 cited by 101

  23. Exaggerated Spontaneous Release of Platelet-Derived Growth Factor by Alveolar Macrophages from Patients with Idiopathic Pulmonary Fibrosis

    Authors: , , , , - New England Journal of Medicine 1987 cited by 418

  24. Carrier frequency for glycogen storage disease type II in New York and estimates of affected individuals born with the disease

    Authors: , , , , , , , , , , - American Journal of Medical Genetics 1998 cited by 214